Table 3 Comparison of baseline parameters between subjects with NAFLD and subjects who did not develop NAFLD (n = 512).
Parameter | Incidence (n = 188) | No incidence (n = 324) | P value |
|---|---|---|---|
Age (yr) | 45.5 (37.0,52.0) | 45 (37.8,54) | 0.778 |
Gender (% male) | 80 (42.6%) | 130 (40.1%) | 0.641 |
BMI (kg/m2) | 24.7 (22.8,26.4) | 22.1 (20.4,23.8) | <0.001* |
WC (cm) | 83.0 (78.0,88.0) | 75.0 (71.0,81.0) | <0.001* |
SBP (mmHg) | 120 (110,135) | 120 (110,130) | 0.265 |
DBP (mmHg) | 80 (75,90) | 80 (70,85) | 0.172 |
GGT (U/L) | 19.1 (13.1,30.7) | 16.0 (12.1,25.3) | 0.024* |
ALT (U/L) | 17.3 (12.8,25.0) | 15.4 (11.5,22.5) | 0.004* |
AST (U/L) | 20.7 (17.6,25.1) | 20.7 (17.6,24.5) | 0.841 |
TC (mmol/l) | 4.03 (3.55,4.65) | 4.14 (3.68,4.77) | 0.366 |
LDL-C (mmol/l) | 2.85 (2.50,3.20) | 2.90 (2.57,3.30) | 0.411 |
HDL-C (mmol/l) | 1.30 (1.10,1.50) | 1.4 (1.20.1.60) | <0.001* |
TG (mmol/l) | 1.22 (0.88,1.80) | 0.98 (0.72,1.46) | <0.001* |
FBG (mmol/l) | 4.71 (4.37,5.09) | 4.66 (4.32,5.12) | 0.366 |
Diabetes, n (%) | 9 (4.8%) | 7 (2.2%) | 0.254 |
Hypertension, n (%) | 63 (33.5%) | 94 (29.0%) | 0.32 |
Obesity, n (%) | 19 (10.1%) | 4 (1.2%) | <0.001* |
Overweight, n (%) | 93 (49.5%) | 74 (22.8%) | |
Dyslipidaemia, n (%) | 84 (44.7%) | 127 (39.2%) | 0.228 |
Hyper-TC, n (%) | 27 (14.4%) | 39 (12.0%) | 0.494 |
Hyper-LDL-C, n (%) | 33 (17.6%) | 73 (22.5%) | 0.213 |
Hyper-TG, n (%) | 49 (26.1%) | 59, (18.2%) | 0.043* |
Hypo-HDL-C, n (%) | 26 (13.8%) | 24 (7.4%) | 0.021* |
